NCT05275166

Brief Summary

Alcohol is the most consumed psychoactive substance in France and is responsible for 49,000 deaths per year in the country. Addictions, characterized by "the repeated impossibility of controlling a behavior and the continuation of this behavior despite the knowledge of its negative consequences", are a major public health issue in France and worldwide. Alcohol dependence (DSM-5 moderate to severe use disorder) is a chronic behavioral disorder, whose main characteristic is its high and prolonged risk of "relapse", i.e. the resumption of problematic consumption after a period of improvement (abstinence or reduction). One of the main components of addiction is "craving", which can be defined as the irrepressible desire to use a substance (DSM-5, American Psychiatric Association). To date, despite functional imaging studies (fMRI), the brain mechanisms involved in craving remain poorly understood. In recent years, a new neuroimaging device has become available, both in research and in clinical settings: high-resolution electroencephalography (HRE). This non-invasive method allows to observe brain activity at the millisecond level. The objective of the CRAVING-NET project is to better understand brain function in alcohol addiction, and in particular in craving.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2023

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 11, 2022

Completed
1.1 years until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 4, 2023

Status Verified

November 1, 2023

Enrollment Period

2 years

First QC Date

March 2, 2022

Last Update Submit

November 28, 2023

Conditions

Keywords

alcoholismelectroencephalographybrain activity

Outcome Measures

Primary Outcomes (1)

  • Source connectivity within large-scale brain networks

    Difference in source connectivity within large-scale brain networks following the induction of craving episodes between alcohol-dependent patients and matched healthy participants (smokers and non-smokers). Source connectivity is measured by the strength of connections between brain regions (ratio value between 0 (no communication) and 1 (strong communication)).

    1 day

Secondary Outcomes (5)

  • Variation in source connectivity based on AUQ

    1 day

  • Variation in source connectivity based on OCDS

    1 day

  • Variation in source connectivity based on psychological state

    1 day

  • Correlation between brain networks estimated by HRE and AUQ and OCDS scores

    6 months

  • Correlation between EEG-HR and fMRI networks at inclusion

    1 day

Study Arms (2)

Patients

OTHER

Patients hospitalized for rehab. HRE following induction of alcohol craving and questionnaires

Behavioral: Induction of alcohol cravingOther: Questionnaires

Healthy Volunteers

OTHER

Healthy Volunteers with non alcohol dependance. HRE following induction of alcohol craving and questionnaires

Behavioral: Induction of alcohol cravingOther: Questionnaires

Interventions

Presentation of images that may induce craving for alcohol. Recording of brain activity

Healthy VolunteersPatients

Questionnaires related to alcohol, quality of life, anxiety and depression

Healthy VolunteersPatients

Eligibility Criteria

Age30 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients (N=20):
  • Subject with moderate to severe DSM-5 alcohol use disorder hospitalized for withdrawal as part of their routine care.
  • Presence of spontaneous and/or in response to environmental stimuli (induced) self-described episodes of craving.
  • Males with age ≥ 30 years and ≤ 60 years;
  • Normal or corrected-to-normal visual acuity (declarative);
  • Right-handed;
  • Healthy control volunteers (N=40):
  • Men with age ≥ 30 years and ≤ 60 years;
  • Normal or corrected-to-normal visual acuity;
  • Right-handed;
  • Smoker (current user, N=20) or Nonsmoker (never smoked, N=20);
  • Alcohol consumption below the low-risk drinking threshold (\<10 standard drinks per week)

You may not qualify if:

  • For all subjects:
  • Alcohol use in the 24 hours prior to the experiment;
  • Consumption of psychoactive substances other than tobacco and alcohol (positive urine test).
  • Presence of a contraindication related to the MRI technique
  • Being under legal protection, and/or deprived of freedom;
  • Not mastering the French language (written and oral);
  • Inability to understand the information given on the study and/or to carry out the experimental task.
  • For patients:
  • Presence of cognitive impairment (MoCA score \< 25)
  • Absence of spontaneous or induced craving episodes
  • Decompensated cirrhosis: ascites and/or encephalopathy and/or jaundice and/or recent hemorrhage
  • For healthy control volunteers:
  • Significant medical or surgical history related to the central nervous system;
  • Current use (\< 30 days) of drugs affecting the central nervous system belonging to the class of antidepressants, sleeping pills and/or anxiolytics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alcoholism

Interventions

EthanolSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Romain Moirand, Pr

    CHU Rennes

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2022

First Posted

March 11, 2022

Study Start

May 1, 2023

Primary Completion

May 1, 2025

Study Completion

November 1, 2025

Last Updated

December 4, 2023

Record last verified: 2023-11